Originova Medical is developing an innovative injectable hydrogel that is designed to address the long-term damage caused by myocardial infarction (MI), commonly known as a heart attack. This hydrogel, when injected into the heart tissue, helps in reducing scarring and enhances tissue regeneration, promoting better recovery and function. With a focus on improving clinical outcomes, Originova Medical aims to revolutionize the treatment of heart attack patients and significantly improve their quality of life.
Company Details
- Employees
- 2
- Founded
- -
- Address
- The Long-Term Damage Caused By Myocardial Infarction (Mi)
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Originova Medical Pty Ltd Questions
Originova Medical Pty Ltd's website is https://www.originovamedical.com/
Originova Medical Pty Ltd's LinkedIn profile is https://www.linkedin.com/company/originova-medical
Originova Medical Pty Ltd has
2 employees.
View email and phone details for 2
employees at Originova Medical Pty Ltd.
Originova Medical Pty Ltd's industry is
Biotechnology Research
Originova Medical Pty Ltd's top competitors are
Icon Strategic Solutions,
Nsw Health,
Medical Recruitment Strategies,
Cardiolife Medtech Pty Ltd.
Originova Medical Pty Ltd's categories are Biotechnology Research
Originova Medical Pty Ltd's founding year is 2024
